CNBC 快讯 10月1日 16:04 摩根大通表示：这家专注癌症精准治疗的生物科技公司股价有望近三倍上涨 This biotech making precision medicines for cancer could nearly triple, says JPMorgan Kura Oncology's pipeline of drugs show promise for the biotech stock. FG 100 读报告 →